List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 128 studies with search of: "Dasatinib"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Not yet recruiting Study of Dasatinib and Bendamustine in Chronic Lymphocytic Leukemia
Condition: Chronic Lymphocytic Leukemia
Interventions: Drug: Dasatinib;   Drug: Combination of Bendamustine + Dasatinib;   Drug: Dasatinib;   Drug: Combination of Bendamustine + Dasatinib
2 Recruiting Study of Dasatinib in Patients With Chronic Myelogenous Leukemia
Condition: Chronic Myelogenous Leukemia
Interventions: Drug: Dasatinib (BMS-354825);   Drug: Dasatinib
3 Completed Study of Dasatinib(BMS-354825) in Patients With Solid Tumors
Condition: Tumors
Interventions: Drug: dasatinib;   Drug: dasatinib;   Drug: dasatinib;   Drug: dasatinib
4 Completed Study of BMS-354825 in Subjects With CML Who Are Resistant to or Intolerant of Imatinib or Ph+All in Japan
Condition: Chronic Myelogenous Leukemia
Interventions: Drug: Dasatinib;   Drug: Dasatinib;   Drug: Dasatinib;   Drug: Dasatinib;   Drug: Dasatinib;   Drug: Dasatinib
5 Active, not recruiting Chronic Myelogenous Leukemia (CML) - Follow on: Study of BMS-354825 in Subjects With CML
Condition: Myeloid Leukemia, Chronic, Chronic-Phase
Interventions: Drug: dasatinib;   Drug: dasatinib;   Drug: dasatinib;   Drug: dasatinib
6 Active, not recruiting Advanced Chronic Myelogenous Leukemia (CML) - Follow On: Study of BMS-354825 in Subjects With CML
Conditions: Myeloid Leukemia, Chronic, Accelerated Phase;   Leukemia, Lymphoblastic, Acute, Philadelphia-Positive
Interventions: Drug: dasatinib;   Drug: dasatinib;   Drug: dasatinib;   Drug: dasatinib
7 Completed A Study of Dasatinib to See How Liver Impaired and Healthy Subjects Process and React to the Study Drug
Condition: Liver Diseases
Interventions: Drug: Dasatinib;   Drug: Dasatinib;   Drug: Dasatinib
8 Recruiting Therapy of Chronic Lymphocytic Leukemia With Dasatinib (BMS-354825)
Conditions: Leukemia;   Lymphoma
Intervention: Drug: Dasatinib (BMS-354825)
9 Active, not recruiting A Study of Dasatinib in Chronic Phase Philadelphia Chromosome Positive Chronic Myeloid Leukemia
Condition: Myeloid Leukemia, Chronic
Interventions: Drug: Dasatinib;   Drug: dasatinib
10 Recruiting Dasatinib in Relapsed or Refractory Non-Hodgkin's Lymphoma
Condition: Non-Hodgkin's Lymphoma
Interventions: Drug: Dasatinib;   Drug: Dasatinib;   Drug: Dasatinib
11 Recruiting A Phase I/Expansion Study of Dasatinib
Conditions: Refractory Solid Tumors;   Pancreatic Adenocarcinoma
Interventions: Drug: gemcitabine;   Drug: dasatinib;   Drug: gemcitabine;   Drug: dasatinib
12 Recruiting A Phase II Study of Dasatinib in Children and Adolescents With Relapsed or Refractory Leukemia
Condition: Leukemia
Interventions: Drug: Dasatinib;   Drug: Dasatinib
13 Recruiting Ph I Dasatinib + Erlotinib in Recurrent MG
Conditions: Glioblastoma;   Gliosarcoma
Intervention: Drug: Erlotinib and Dasatinib
14 Not yet recruiting Personalized Treatment Selection for Dasatinib in Metastatic Breast Cancer
Condition: Breast Cancer
Intervention: Drug: Dasatinib
15 Recruiting PH I SRC Kinase, Dasatinib Combo Paclitaxel & Carboplatin in Pts w Ovarian, Peritoneal, & Tubal Cancer
Conditions: Ovarian Cancer;   Peritoneal Cancer;   Tubal Cancer
Intervention: Drug: Dasatinib, Paclitaxel, and Carboplatin
16 Recruiting Dasatinib Plus Radiation Therapy/Temozolomide in Newly-Diagnosed Glioblastoma
Conditions: Glioblastoma;   CNS Disease;   Brain Diseases
Interventions: Drug: Dasatinib;   Radiation: RT (Radiotherapy);   Drug: TMZ (Temozolomide)
17 Active, not recruiting Dasatinib in Patients With Head and Neck Squamous Cell Carcinoma
Conditions: Head and Neck Cancer;   Squamous Cell Carcinoma
Intervention: Drug: Dasatinib
18 Recruiting Comparison of Biomarker Modulation by Inhibition of EGFR and/or SRC Family
Conditions: Head and Neck Cancer;   Non Small Cell Lung Cancer
Interventions: Drug: Erlotinib;   Drug: Dasatinib plus Placebo;   Drug: Erlotinib plus Dasatinib;   Drug: Placebo;   Drug: Erlotinib
19 Recruiting Dasatinib in Resectable Malignant Pleural Mesothelioma
Condition: Malignant Pleural Mesothelioma
Intervention: Drug: Dasatinib
20 Recruiting Dasatinib and Erlotinib in Non-Small Cell Lung Cancer (NSCLC)
Conditions: Lung Cancer;   Non-Small Cell Lung Cancer
Interventions: Drug: Dasatinib;   Drug: Erlotinib

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services